Cell Therapy for Chronic Stroke
- 1 May 2018
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 49 (5), 1066-1074
- https://doi.org/10.1161/strokeaha.117.018290
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Proteomic Analysis of the Extracellular Matrix Produced by Mesenchymal Stromal Cells: Implications for Cell Therapy MechanismPLOS ONE, 2013
- Intrathecal Administration of Autologous CD34 Positive Cells in Patients with Past Cerebral Infarction: A Safety StudyISRN Neurology, 2013
- Comparing the angiogenic potency of naïve marrow stromal cells and Notch-transfected marrow stromal cellsJournal of Translational Medicine, 2013
- Devices for cell transplantation into the central nervous system: Design considerations and emerging technologiesSurgical Neurology International, 2013
- Therapeutic Effects of hMAPC and hMSC Transplantation after Stroke in MicePLOS ONE, 2012
- Sham Surgery Trial Controls: Perspectives of Patients and Their RelativesJournal of Empirical Research on Human Research Ethics, 2012
- Intra-Arterial Delivery of Cell Therapies for StrokeStem Cells and Development, 2012
- Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trialThe Lancet Neurology, 2011
- Functional assessments in the rodent stroke modelExperimental & Translational Stroke Medicine, 2010
- Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke modelExperimental & Molecular Medicine, 2008